Page last updated: 2024-10-26

etidronate and Rhabdomyosarcoma, Alveolar

etidronate has been researched along with Rhabdomyosarcoma, Alveolar in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Rhabdomyosarcoma, Alveolar: A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. Alveolar refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed, p2188)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oğuz, A1
Karadeniz, C1
Cağlar, E1
Cağlar Citak, E1
Ataoğlu, O1

Other Studies

1 other study available for etidronate and Rhabdomyosarcoma, Alveolar

ArticleYear
The use of etidronate in therapy-resistant hypercalcemia.
    Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:1

    Topics: Adolescent; Etidronic Acid; Head and Neck Neoplasms; Humans; Hypercalcemia; Male; Rhabdomyosarcoma,

1999